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Run program 
every 5 years 
Undiagnosed 
FH decreases 
Plan 
implemented 
in more cities
Focused on Worcester, MA
Accessible 
Has locations that 
attract ethnicities with higher 
prevalence to FH
Camryn Berry (BME), Shanna Bonanno (BME), Michelle Fleming (ME), Deborah Fontanez (ME), and Talia Vaughn (BME)
Advisors: Professor Jill Rulfs and Professor Helen Vassallo
To reduce the number of people suffering from undiagnosed Familial Hypercholesterolemia (FH) in Worcester, Massachusetts.
Goal
Are You the One?
Fill out emergency and 
consent form.
A finger prick will test total 
cholesterol levels. 
Lab will notify patients of 
cholesterol levels.
Patients will be referred to 
PCP for further testing
Conclusion
MethodWhat is FH?
Where?
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Program Execution Year
Undiagnosed FH Patients in 
Worcester, MA
Future Plans
This disease affects 
1 in 250 
people
Familial Hypercholesterolemia in Worcester, MA
References
High Risk Early Death
Life expectancy 
reduced by 15-
30 years. 
A genetic disease that causes 
dangerously high levels of cholesterol.
Heart Attack 
Stoke 
Funding increases, as the 
program and FH becomes 
more well-known
Percent of undiagnosed FH cases 
continue to drop over the years
Deaths by heart attack and stroke   
decrease
